The “Understanding endemic Rift Valley Fever (RVF) transmission in distinct African regions” project was initiated in 2026. It investigates the endemic dynamics of Rift Valley Fever virus (RVFV) in East (Kenya), West (Senegal), and Southern Africa (Mozambique), challenging the view of RVFV as an epidemic disease. We propose that RVF exists along a spectrum from epidemic to endemic transmission, influenced by landscape ecology, climate, and socioeconomic factors.
- We will analyse existing RVF datasets and collect new field data to quantify endemic transmission in areas where humans and livestock share ecological niches with mosquito vectors.
- We will conduct cohort studies to estimate RVFV seroconversion in livestock and humans.
- We will characterize mosquito vectors, investigate environmental factors influencing virus persistence, and use genomic tools to sequence RVFV from animals, humans, and vectors for phylogeographic analysis.
- We will conduct ethnographic research to explore social perceptions of RVF risk and responses.
By integrating ecological, phylogeographical, and social data, this research will engage with communities, national authorities, and international bodies to provide policymakers with evidence-based strategies for sustainable RVFV control, shifting from reactive outbreak responses to proactive prevention.
This work is a collaboration that is being led by ILRI in partnership with the University of Pretoria, Kenya Medical Research Institute, University of Global Health Equity, Makerere University, MRC Unit The Gambia, Médecine Vétérinaire de l’Université de Lubumbashi, Eduardo Mondlane University, Instituto Nacional de Saúde (INS), Mozambique, One Health Research Consulting, Durham University, CIRAD, Institut Pasteur de Dakar.
This project is funded by the Wellcome Trust.